Cargando…

Achievement of LDL-C Targets Defined by ESC/EAS (2011) Guidelines in Risk-Stratified Korean Patients with Dyslipidemia Receiving Lipid-Modifying Treatments

BACKGROUND: This study assessed the proportion of risk-stratified Korean patients with dyslipidemia achieving their low-density lipoprotein cholesterol (LDL-C) targets as defined by the European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) (2011) guidelines while receiving lipid-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Ye Seul, Lee, Seo Young, Kim, Jung-Sun, Choi, Kyung Mook, Lee, Kang Wook, Lee, Sang-Chol, Cho, Jung Rae, Oh, Seung-Jin, Kim, Ji-Hyun, Choi, Sung Hee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Endocrine Society 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386099/ https://www.ncbi.nlm.nih.gov/pubmed/32615721 http://dx.doi.org/10.3803/EnM.2020.35.2.367

Ejemplares similares

The DA VINCI study: is Ireland achieving ESC/EAS guideline–directed LDL-C goals?
por: Offiah, Gregory, et al.
Publicado: (2022)

Can we achieve ESC 2019 guidelines LDL-cholesterol target in Tunisia?
por: Ibn Elhadj, Zied, et al.
Publicado: (2022)

Achievement of Low-Density Lipoprotein Cholesterol Targets in Cardiac Rehabilitation: Impact of the 2019 ESC/EAS Dyslipidaemia Guidelines
por: Haegele, Matthias, et al.
Publicado: (2022)

Best Achievements in Clinical Medicine in Diabetes and Dyslipidemia in 2020
por: Rhee, Eun-Jung, et al.
Publicado: (2021)

Implications of ACC/AHA Versus ESC/EAS LDL-C Recommendations for Residual Risk Reduction in ASCVD: A Simulation Study From DA VINCI
por: Vallejo-Vaz, Antonio J., et al.
Publicado: (2022)

Type of dyslipidemia and achievement of the LDL-cholesterol goal in chronic kidney disease patients at the University Hospital
por: Sangsawang, Tamon, et al.
Publicado: (2015)

Ethyl pyruvate inhibits oxidation of LDL in vitro and attenuates oxLDL toxicity in EA.hy926 cells
por: Rossmann, Christine, et al.
Publicado: (2018)

Effect of physician characteristics and knowledge on the quality of dyslipidemia management and LDL–C target goal achievement in China: Subgroup analysis of the Dyslipidemia International Study
por: Ding, Rongjing, et al.
Publicado: (2017)

How can we further improve the LDL-cholesterol target level achievement rate based on the Hungarian MULTI GAP 2011 study results and considering the new European dyslipidemia guidelines?
por: Mark, Laszlo, et al.
Publicado: (2012)

ALERT-LDL: adherence to guidelines in the treatment of patients with dyslipidemia
por: Bosso, Giorgio, et al.
Publicado: (2021)

Dyslipidaemia management in the cardiac rehabilitation clinic of a tertiary referral centre: analysis of the impact of new ESC guidance on LDL-C target achievement
por: McCaughey, Conor, et al.
Publicado: (2022)

New Therapeutic Approaches to the Treatment of Dyslipidemia 2: LDL-C and Lp(a)
por: Kim, Kyung An, et al.
Publicado: (2023)

Low-density lipoprotein-cholesterol target attainment according to the 2011 and 2016 ESC/EAS dyslipidaemia guidelines in patients with a recent myocardial infarction: nationwide cohort study, 2013–17
por: Allahyari, Ali, et al.
Publicado: (2020)

Seeding hESCs to achieve optimal colony clonality
por: Wadkin, L. E., et al.
Publicado: (2019)

Effect of alirocumab dose increase on LDL lowering and lipid goal attainment in patients with dyslipidemia
por: Kastelein, John J.P., et al.
Publicado: (2017)

Application of the 2019 ESC/EAS dyslipidaemia guidelines to nationwide data of patients with a recent myocardial infarction: a simulation study
por: Allahyari, Ali, et al.
Publicado: (2020)

Apolipoprotein E4 Exaggerates Diabetic Dyslipidemia and Atherosclerosis in Mice Lacking the LDL Receptor
por: Johnson, Lance A., et al.
Publicado: (2011)

Dyslipidemia-Induced Neuropathy in Mice: The Role of oxLDL/LOX-1
por: Vincent, Andrea M., et al.
Publicado: (2009)

Endothelial Function in Dyslipidemia: Roles of LDL-Cholesterol, HDL-Cholesterol and Triglycerides
por: Higashi, Yukihito
Publicado: (2023)

ACC/AHA guidelines superior to ESC/EAS guidelines for primary prevention with statins in non-diabetic Europeans: the Copenhagen General Population Study
por: Mortensen, Martin Bødtker, et al.
Publicado: (2017)

A 10- and 15-year performance analysis of ESC/EAS and ACC/AHA cardiovascular risk scores in a Southern European cohort
por: Santos-Ferreira, Cátia, et al.
Publicado: (2020)

Comparison of Framingham risk score and pooled cohort equations for the prediction of coronary atherosclerosis in patients who meet the target LDL-C level of Korean dyslipidemia guideline
por: Kim, Su Bin, et al.
Publicado: (2022)

2018 Guidelines for the management of dyslipidemia
por: Rhee, Eun-Jung, et al.
Publicado: (2019)

Platycodin D enhances LDLR expression and LDL uptake via down-regulation of IDOL mRNA in hepatic cells
por: Choi, Yu-Jeong, et al.
Publicado: (2020)

Therapeutic Target Achievement in Type 2 Diabetic Patients after Hyperglycemia, Hypertension, Dyslipidemia Management
por: Kang, Ah Young, et al.
Publicado: (2011)

Epidemiological Characteristics of Imported Shigellosis in Korea, 2010–2011
por: Kim, Hee-Jung, et al.
Publicado: (2013)

LDL cholesterol-lowering effect of Daeshiho-tang in patients with dyslipidemia: A pilot randomized, double-blind, placebo-controlled trial
por: Noh, Ji-Won, et al.
Publicado: (2023)

2018 Guidelines for the Management of Dyslipidemia in Korea
por: Rhee, Eun-Jung, et al.
Publicado: (2019)

2018 Guidelines for the management of dyslipidemia in Korea
por: Rhee, Eun-Jung, et al.
Publicado: (2019)

Physicochemical Characterization of In Vitro LDL Glycation and Its Inhibition by Ellagic Acid (EA): An In Vivo Approach to Inhibit Diabetes in Experimental Animals
por: Ahmad, Saheem, et al.
Publicado: (2022)

What Number of Oocytes Is Appropriate for Defining Poor Ovarian Response?
por: Kim, Seul Ki, et al.
Publicado: (2015)

Lotus leaf alleviates hyperglycemia and dyslipidemia in animal model of diabetes mellitus
por: Kim, Ah-Rong, et al.
Publicado: (2013)

Synergistic effect of fruit–seed mixed juice on inhibition of angiotensin I-converting enzyme and activation of NO production in EA.hy926 cells
por: Park, Hye-Jung, et al.
Publicado: (2018)

The Observation System of EAS Muon Component with the EAS Array and the Muon Spectrometer
por: Tsuji, S
Publicado: (2005)

Association between Gout and Dyslipidemia: A Nested Case–Control Study Using a National Health Screening Cohort
por: Choi, Hyo Geun, et al.
Publicado: (2022)

hESC Expansion and Stemness Are Independent of Connexin Forty-Three-Mediated Intercellular Communication between hESCs and hASC Feeder Cells
por: Kim, Jin-Su, et al.
Publicado: (2013)

Crystal Structure and Functional Characterization of an Esterase (EaEST) from Exiguobacterium antarcticum
por: Lee, Chang Woo, et al.
Publicado: (2017)

Lipid-lowering therapies and achievement of LDL-cholesterol targets
por: Rizzo, Manfredi, et al.
Publicado: (2012)

Optimal implementation of the 2019 ESC/EAS dyslipidaemia guidelines in patients with and without atherosclerotic cardiovascular disease across Europe: a simulation based on the DA VINCI study
por: Brandts, Julia, et al.
Publicado: (2023)

Helicobacter pylori is associated with dyslipidemia but not with other risk factors of cardiovascular disease
por: Kim, Tae Jun, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jiacfkcfv3te03uc272hqa9phr